[Therapy-Related Acute Myeloid Leukemia Following Etoposide Based Chemotherapy in Germ Cell Tumor].
暂无分享,去创建一个
[1] P. Hall,et al. Risk of leukemia among survivors of testicular cancer: a population-based study of 42,722 patients. , 2007, Annals of epidemiology.
[2] Bingshu E. Chen,et al. Comparative mortality for 621 second cancers in 29356 testicular cancer survivors and 12420 matched first cancers. , 2007, Journal of the National Cancer Institute.
[3] J. Olsen,et al. Second malignancies among survivors of germ‐cell testicular cancer: A pooled analysis between 13 cancer registries , 2007, International journal of cancer.
[4] A. Horwich,et al. Mortality and incidence of second cancers following treatment for testicular cancer , 2007, British Journal of Cancer.
[5] C. Bokemeyer,et al. Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer , 2005, Journal of Cancer Research and Clinical Oncology.
[6] M. Seto,et al. Therapy-related leukemia and myelodysplastic syndrome: a large-scale Japanese study of clinical and cytogenetic features as well as prognostic factors. , 2000, International journal of hematology.
[7] C. Bokemeyer,et al. Therapy‐related malignancies following treatment of germ cell cancer , 1999, International journal of cancer.
[8] Y. Oji,et al. Secondary acute monocytic leukemia occurring during the treatment of a testicular germ cell tumor. A case report and review of the literature. , 1997, Urologia internationalis.
[9] S. Nakazawa,et al. High Frequency of Etoposide (VP‐16)-Related Secondary Leukemia in Children with Non‐Hodgkin's Lymphoma , 1993, The American journal of pediatric hematology/oncology.